Week 3 RA 4688 - Clinical-Laboratory-Law
Week 3 RA 4688 - Clinical-Laboratory-Law
Week 3 RA 4688 - Clinical-Laboratory-Law
Laboratory Law
RA 4688
& Its Implementing Guidelines
(AO # 2007-0027)
RA 4688
The Clinical Laboratory Act of 1966
• E. Monitoring
– BHFS/CHD Director or rep shall monitor clinical labs
– Notice of violation for non-compliant labs shall be issued
immediately
– CHD concerned shall submit quarterly summary of
violations to BHFS
– Provincial, City & Municipal Health Officers can report
existence of unlicensed labs
• VIII. Schedule of Fees
• IX. Violations
– Refusal on any clinical lab to participate in EQAP
– Issuance of a report, orally or in writing (in whole or
part thereof) which is not in accordance w/
documented procedures
– Permitting unauthorized persons to perform technical
procedures
– Incompetence
– Deviations from standard test procedures
– Lending or using the name of licensed lab or head or
RMT to an unlicensed lab
– Unauthorized use of the name and signature
of Pathologist and RMT to secure LTO
– Reporting a test result for clinical specimens
even if the test was not actually done
– Transferring results of tests done in an
outside lab to the result form of the referring
lab
– Performing and reporting tests in a specialty
or subspecialty in which the lab is not licensed
– Giving and receiving any commission, bonus
or kickback or rebate or engaging in any split-
free for referral to clinical labs licensed by
DOH
• X. Investigation of Charges or Complaints
– BHFS/CHD Dir or rep shall investigate the complaint
– BHFS/CHD Dir or rep shall suspend, cancel or revoke
& may seek any law enforcement agency to execute
the closure of any erring lab when necessary
• XI. Penalty
– Imprisonment of not less than 1 month; or
– Fine not less than PhP 1000 but no more than PhP
5000; or
– Both
– If a corporation- managing head or owner is liable
• XII. Appeal
– Office of the Health Sec w/n 10 days after
receipt of notice of decision
– Decision is final & executory
• XIII. Repealing Clause
• XIV. Separability Clause
• XV. Effectivity
Technical Standards
and Minimum Requirements
• Staffing
– Managed by licensed Physician certified by the
Philippine Board of Pathology
• If not available – w. 3 mos training on clinical lab medicine,
QC & management may manage a primary/secondary lab as
certified by BHFS
– RMTs – available at all times during operation hours
• Hospital-based lab – at least 1 RMT/shift
– Staff development & CPE program instituted
• Physical Facilities
– Well-ventilated, adequately lighted, clean &
safe
– Work space reqt’s (at least)
• 1º - 10 m2
• 2º - 20 m2
• 3º - 60 m2
Equipment/Instruments
Primary Secondary Tertiary
Clinical centrifuge All those in 1º plus the All those in 2º plus the
ff: ff:
Hemacytometer Refrigerator Incubator
Microhematocrit Photometer or its Balance
centrifuge equivalent
Microscope with OIL Waterbath or its Rotator
equivalent
Hemoglobinometer or Timer or its equivalent Serofuge or its
equivalent equivalent
Differential counter or Autoclave
equivalent
Drying oven
Biosafety cabinet (BSC)
or equivalent
• Glasswares/Reagents/Supplies
• Waste Management
• Quality Control Program
– Internal QC
– External QC
• All labs shall participate in an EQAS given by designated
NRL
• Satisfactory performance rating – criteria for renewal of
license
• Refusal to participate in EQAS-NRL – basis for
suspension/revocation of license
• Reporting
– Bear the name & signature of Pathologist & RMT
– No report orally or in writing without directive from
pathologist or associate except in emergency cases
• Recording
– All requests and reports of all specimens submitted
and examined
– Kept in file for at least 1 year
• Anatomic and forensic pathology reports are kept
permanently
• Laboratory Fees
End of R.A.
4688
Assignment
• Read and study R. A. 4688
• Quiz next meeting